Expansion3 Sept 2025, 09:01 pm
Sanjivani Paranteral Ltd Expands Global Presence, Reports Strong FY25 Performance
AI Summary
Sanjivani Paranteral Ltd reported a robust financial year 2024-25, marked by strategic expansions, product launches, and deeper penetration into key geographies. The company strengthened its base business and laid the groundwork for the next phase of growth through strategic joint ventures, reinforcing its position as a trusted global partner in life-saving medicines. FY26 is set to be a pivotal year with all three growth engines contributing simultaneously, driving scale, diversification, and resilience.
Key Highlights
- Strategic expansions into Latin America, Central America, the Middle East, and Francophone Africa
- Strengthened base business through portfolio expansion and product launches
- Laid groundwork for next phase of growth through strategic joint ventures
- All three growth engines to contribute simultaneously in FY26
- Reinforced position as a trusted global partner in life-saving medicines